Word

SANSURE

Status

Registered

Status Code

700

Status Date

Tuesday, February 28, 2023

Serial Number

90036219

Registration Number

6988289

Registration Date

Tuesday, February 28, 2023

Mark Type

4000

Filing Date

Sunday, July 5, 2020

Published for Opposition

Tuesday, December 13, 2022

Trademark Owner History

Sansure Biotech Inc. - Original Registrant

Classifications

5 Injectable pharmaceuticals for treatment of anaphylactic reactions; Chemical reagents for medical purposes; Antibiotic tablets; Allergy tablets; Medicated water for the treatment of illnesses attributed to insufficient cellular energy; Medicated water for the treatment of allergies, cough, cold, flu, headache, pain; Medicated water for the treatment of infectious diseases, skin diseases and conditions, and internal diseases and conditions; Medicated water for the treatment of pain, nausea and muscle spasms; Medicated water-based solutions for treating skin infections and skin conditions; Medicated water for the treatment of gastrointestinal disorders; Antibiotic ointments; Anti-inflammatory ointments; Medicated ointments for treating dermatological conditions; Purified biochemical medical diagnostic reagents, namely, protein arrays, enzymes, and fluorescent dyes; Biochemical drugs for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; Diagnostic preparations for medical purposes; Chemico-pharmaceutical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory system; Chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory systems; Chemical preparations in the nature of biological indicators, in-vivo diagnostic agents, in-vitro diagnostic reagents for the diagnosis, monitoring, treatment and prevention of cancer, inflammatory disorders, oncological disorders, infectious diseases, and diseases related to the immune system and respiratory system; Chemical reagents for medical or veterinary purposes

35 Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies

10 Surgical apparatus and instruments; Blood testing apparatus; Dropping pipettes for medical purposes; Medical devices in the nature of a nucleic acid analyzer for medical diagnosis; Diagnostic apparatus for medical and veterinary purposes, in particular for detecting target nucleic acid molecules in a sample, in particular in a patient sample; Medical apparatus for purifying nucleic acids; Medical nucleic acid amplification and detection apparatus; Medical equipment, namely, devices for bioanalysis of pathogens incorporating cartridges for sample preparation, nucleic acid purification, nucleic acid amplification and electrochemical detection for medical diagnostic purposes, and recorded computer operating software, recorded smartphone operating software provided therein sold as a unit; Medical laboratory instruments for diagnostic use and medical diagnostic instruments, namely, nucleic acid sequencers and synthesizers, genetic analyzers, fragment analyzers, electrophoresis machines, linkage analyzers, genetic mappers, thermal cyclers, cytometer, chemical reaction mixture containment apparatus and structural parts thereof, protein and peptide synthesizers, mass spectrometer and chromatograph, high-throughput instruments for preparation of nucleic acid samples; Apparatus for use in medical analysis, namely, apparatus for blood analysis, body composition analyzers, apparatus for analyzing and detecting bacteria and viruses, apparatus for analyzing and detecting DNA and RNA, apparatus for analyzing and detecting genes, apparatus for analyzing blood vessels, apparatus for cavitation detecting, and apparatus for imaging analysis; Diagnostic apparatus for medical purposes comprising diagnostic imaging apparatus, displays, monitors and recorded computer operating software, recorded smartphone operating software therefor sold as a unit; Immunochemical testing apparatus for medical use; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other bodily fluids-based, tissue-based, organ-based diagnostic testing, cytology, cell-based, nucleic acid- based, genes-based testing; Analysers for bacterial identification for medical purposes; Apparatus for DNA and RNA testing for medical purposes; Scientific apparatus and instruments, namely, nucleic acid sequencers for use in medical and veterinary diagnosis and in medical and veterinary treatment in the fields of nucleic acid sequencing, genotyping, and genetics

SAN SURE

Trademark Events

Feb 28, 2023

Notice Of Registration Confirmation Emailed

Feb 28, 2023

Registered-Principal Register

Dec 13, 2022

Official Gazette Publication Confirmation E-Mailed

Dec 13, 2022

Published For Opposition

Nov 23, 2022

Notification Of Notice Of Publication E-Mailed

Nov 7, 2022

Approved For Pub - Principal Register

Nov 4, 2022

Examiner's Amendment Entered

Nov 4, 2022

Notification Of Examiners Amendment E-Mailed

Nov 4, 2022

Examiners Amendment E-Mailed

Nov 4, 2022

Examiners Amendment -Written

Nov 4, 2022

Previous Allowance Count Withdrawn

Nov 4, 2022

Notice Of Allowance Cancelled

Oct 17, 2022

Attorney Review/Decision On Amendment Required

Oct 17, 2022

Petition To Director - Change Basis - Granted

Oct 13, 2022

Teas Response To Petition To Director Inquiry

Oct 5, 2022

Petition Inquiry Letter Issued

Oct 5, 2022

Review Of Correspondence Complete

Oct 3, 2022

Assigned To Petition Staff

Sep 13, 2022

Notice Of Approval Of Extension Request E-Mailed

Sep 10, 2022

Teas Post Publication Amendment Received

Sep 10, 2022

Sou Extension 2 Granted

Sep 10, 2022

Sou Extension 2 Filed

Sep 10, 2022

Teas Extension Received

Sep 7, 2022

Teas Petition To Amend Basis Received

Apr 22, 2022

Notice Of Approval Of Extension Request E-Mailed

Apr 22, 2022

Corrected Noa E-Mailed

Apr 21, 2022

Sou Extension 1 Granted

Apr 4, 2022

Sou Extension 1 Filed

Apr 21, 2022

Divisional Processing Complete

Apr 4, 2022

Divisional Request Received

Apr 20, 2022

Case Assigned To Intent To Use Paralegal

Apr 4, 2022

Teas Request To Divide Received

Apr 4, 2022

Teas Extension Received

Oct 19, 2021

Noa E-Mailed - Sou Required From Applicant

Aug 24, 2021

Official Gazette Publication Confirmation E-Mailed

Aug 24, 2021

Published For Opposition

Aug 4, 2021

Notification Of Notice Of Publication E-Mailed

Jul 22, 2021

Approved For Pub - Principal Register

Jul 10, 2021

Teas/Email Correspondence Entered

Jul 9, 2021

Correspondence Received In Law Office

Jul 9, 2021

Teas Response To Office Action Received

Jan 11, 2021

Notification Of Non-Final Action E-Mailed

Jan 11, 2021

Non-Final Action E-Mailed

Jan 11, 2021

Non-Final Action Written

Dec 28, 2020

Assigned To Examiner

Dec 1, 2020

Assigned To Examiner

Nov 4, 2020

Assigned To Examiner

Oct 19, 2020

Assigned To Examiner

Oct 13, 2020

Assigned To Examiner

Jul 31, 2020

New Application Office Supplied Data Entered

Jul 8, 2020

New Application Entered